JP2014503544A5 - - Google Patents

Download PDF

Info

Publication number
JP2014503544A5
JP2014503544A5 JP2013545540A JP2013545540A JP2014503544A5 JP 2014503544 A5 JP2014503544 A5 JP 2014503544A5 JP 2013545540 A JP2013545540 A JP 2013545540A JP 2013545540 A JP2013545540 A JP 2013545540A JP 2014503544 A5 JP2014503544 A5 JP 2014503544A5
Authority
JP
Japan
Prior art keywords
methyl
alkyl
pyrazol
fluorophenyl
pyrrolo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013545540A
Other languages
English (en)
Japanese (ja)
Other versions
JP5684923B2 (ja
JP2014503544A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2011/055489 external-priority patent/WO2012085721A1/en
Publication of JP2014503544A publication Critical patent/JP2014503544A/ja
Publication of JP2014503544A5 publication Critical patent/JP2014503544A5/ja
Application granted granted Critical
Publication of JP5684923B2 publication Critical patent/JP5684923B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013545540A 2010-12-20 2011-12-06 カゼインキナーゼ阻害剤としての新規縮合ピリジン化合物 Active JP5684923B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201061425213P 2010-12-20 2010-12-20
US61/425,213 2010-12-20
PCT/IB2011/055489 WO2012085721A1 (en) 2010-12-20 2011-12-06 Novel fused pyridine compounds as casein kinase inhibitors

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015005142A Division JP5876596B2 (ja) 2010-12-20 2015-01-14 カゼインキナーゼ阻害剤としての新規縮合ピリジン化合物

Publications (3)

Publication Number Publication Date
JP2014503544A JP2014503544A (ja) 2014-02-13
JP2014503544A5 true JP2014503544A5 (index.php) 2015-01-15
JP5684923B2 JP5684923B2 (ja) 2015-03-18

Family

ID=45446116

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2013545540A Active JP5684923B2 (ja) 2010-12-20 2011-12-06 カゼインキナーゼ阻害剤としての新規縮合ピリジン化合物
JP2015005142A Active JP5876596B2 (ja) 2010-12-20 2015-01-14 カゼインキナーゼ阻害剤としての新規縮合ピリジン化合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2015005142A Active JP5876596B2 (ja) 2010-12-20 2015-01-14 カゼインキナーゼ阻害剤としての新規縮合ピリジン化合物

Country Status (23)

Country Link
US (1) US8536164B2 (index.php)
EP (2) EP3181133B1 (index.php)
JP (2) JP5684923B2 (index.php)
KR (1) KR101590236B1 (index.php)
CN (1) CN103260622B (index.php)
AR (1) AR084412A1 (index.php)
AU (1) AU2011346733C1 (index.php)
CA (1) CA2819961C (index.php)
CY (2) CY1118772T1 (index.php)
DK (2) DK2654750T3 (index.php)
ES (2) ES2744099T3 (index.php)
HR (2) HRP20170484T1 (index.php)
HU (2) HUE047089T2 (index.php)
IL (1) IL226948A (index.php)
LT (2) LT2654750T (index.php)
MX (1) MX338551B (index.php)
PL (2) PL2654750T3 (index.php)
PT (2) PT2654750T (index.php)
RS (2) RS59098B1 (index.php)
SG (1) SG190802A1 (index.php)
SI (2) SI3181133T1 (index.php)
WO (1) WO2012085721A1 (index.php)
ZA (1) ZA201303453B (index.php)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2493876T3 (pl) * 2009-10-28 2014-06-30 Pfizer Pochodne imidazolu jako inhibitory kinazy kazeinowej
US9938269B2 (en) 2011-06-30 2018-04-10 Abbvie Inc. Inhibitor compounds of phosphodiesterase type 10A
CN104837844B (zh) * 2012-12-21 2017-08-29 百时美施贵宝公司 作为酪蛋白激酶1 d/e抑制剂的吡唑取代的咪唑并哌嗪
WO2015163446A1 (ja) * 2014-04-25 2015-10-29 協和発酵キリン株式会社 イミダゾール化合物の製造方法
JP2017222576A (ja) * 2014-10-31 2017-12-21 石原産業株式会社 有害生物防除剤
CN107365315B (zh) * 2016-05-11 2024-08-09 国药集团国瑞药业有限公司 一种吡唑类化合物、其晶型及其制备方法
US10973820B2 (en) * 2017-12-13 2021-04-13 Facio Intellectual Property B.V. Compounds for treatment of diseases related to DUX4 expression
TW202112368A (zh) * 2019-06-13 2021-04-01 荷蘭商法西歐知識產權股份有限公司 用於治療有關dux4表現之疾病的抑制劑組合
EP4126878A4 (en) * 2020-03-27 2024-07-10 Gritscience Biopharmaceuticals Co., Ltd. COMPOUNDS AS CASEIN KINASE INHIBITORS
CN115335057A (zh) * 2020-03-27 2022-11-11 北京原基华毅生物科技有限公司 抑制酪蛋白激酶的方法
AR122711A1 (es) 2020-06-25 2022-09-28 Alchemedicine Inc COMPUESTO HETEROCÍCLICO COMO INHIBIDOR DE CASEÍNA QUINASA 1d Y/O QUINASA 5 TIPO RECEPTOR DE ACTIVINA
CN111808102B (zh) * 2020-08-03 2021-12-31 南通大学 一种3-甲氧基-6,7-二氢-5H-吡咯并[3,4-b]吡啶盐酸盐及其合成方法
CA3189703A1 (en) * 2020-09-17 2022-03-24 Terry Patrick LEBOLD Casein kinase 1 delta modulators
US20230339970A1 (en) * 2020-09-17 2023-10-26 Janssen Pharmaceutica Nv Casein kinase 1 delta modulators
WO2022115301A1 (en) * 2020-11-24 2022-06-02 Merck Sharp & Dohme Corp. Modified isoindolinones as glucosylceramide synthase inhibitors
US20250275965A1 (en) * 2020-12-15 2025-09-04 Gritscience Biopharmaceuticals Co.,Ltd. Compounds as casein kinase inhibitors
US20230053307A1 (en) * 2021-07-19 2023-02-16 Buddhist Tzu Chi Medical Foundation Method for preventing or treating skin disorders and conditions
CN119487030A (zh) * 2022-06-14 2025-02-18 北京原基华毅生物科技有限公司 作为酪蛋白激酶抑制剂的化合物的盐和/或晶形
CN117362303B (zh) * 2022-07-02 2026-02-03 黑龙江联顺生物科技有限公司 一种生物素中间体环酐的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0151962A3 (en) 1984-01-25 1985-10-02 Beecham Group Plc Pyrazolopyridine derivatives
CN1264377A (zh) * 1997-05-22 2000-08-23 G·D·西尔公司 用作p38激酶抑制剂的取代的吡唑化合物
US6610688B2 (en) * 1999-12-21 2003-08-26 Sugen, Inc. 4-substituted 7-aza-indolin-2-ones and their use as protein kinase inhibitors
SG10201504801VA (en) 2005-06-22 2015-07-30 Chemocentryx Inc Azaindazole compounds and methods of use
US7897595B2 (en) 2006-05-26 2011-03-01 Forest Laboratories Holdings Limited Pyridoazepine derivatives
EP2308866A1 (de) * 2009-10-09 2011-04-13 Bayer CropScience AG Phenylpyri(mi)dinylpyrazole und ihre Verwendung als Fungizide
PL2493876T3 (pl) * 2009-10-28 2014-06-30 Pfizer Pochodne imidazolu jako inhibitory kinazy kazeinowej

Similar Documents

Publication Publication Date Title
JP2014503544A5 (index.php)
JP7654071B2 (ja) 複素環スピロ化合物及び使用方法
HRP20170484T1 (hr) Novi kondenzirani spojevi piridina kao inhibitori kazeinske kinaze
AU2017204248B2 (en) Compounds for treating spinal muscular atrophy
JP2014513139A5 (index.php)
US10975080B2 (en) Compounds and compositions for inhibiting the activity of SHP2
JP2011527684A5 (index.php)
TWI579284B (zh) 咪唑并吡咯啶酮化合物
JP7399848B2 (ja) Rho関連コイルドコイル含有プロテインキナーゼの阻害剤
RU2665036C9 (ru) Гетероароматические соединения-модуляторы фосфоинозидит-3-киназы и способы применения
JP2017510576A5 (index.php)
JP2019536768A5 (index.php)
RU2015105249A (ru) Ингибиторы mtor киназы для онкологических показаний и заболеваний, связанных с mtor/pi3k/akt путем метаболизма
RU2014112931A (ru) Пиразолохинолиновое производное
JP2014513140A5 (index.php)
RU2018134981A (ru) Конъюгаты, содержащие ингибиторы RIPK2
JP2013512953A5 (index.php)
EP3393472A1 (en) 3-(1h-pyrazol-4-yl)pyridine allosteric modulators of the m4 muscarinic acetylcholine receptor
JP2017513887A5 (index.php)
JP2019504102A5 (index.php)
JP2016517877A5 (index.php)
JP2013518823A5 (index.php)
SI2864328T1 (en) Pharmaceutically active compounds
HRP20150707T1 (hr) Novi derivati (heterocikal/kondenzirani piperidin)-(piperazinil)-1-alkanon ili (heterocikal/kondenzirani pirolidin)-(piperazinil)-1-alkanon, i njihova uporaba kao inhibitora p75
WO2019005587A1 (en) ACETYLCHOLINE M4 MUSCARINIC RECEPTOR TYPE 3- (1H-PYRAZOL-4-YL) PYRIDINE MODULATORS